I am deeply honored to have the opportunity to serve as Executive Vice President and Provost, and Dean of the School of Medicine at the University of Texas Medical Branch. I am proud to be part of an institution with such a rich history and diverse community of people who are working to improve the lives of others.

Message from the Provost

July 28, 2014

Dr. Alvin LeBlancAs many of you know, Dr. Alvin LeBlanc passed away on July 21st. I wanted to write about Dr. LeBlanc’s tremendous contributions to UTMB, the community and society-at-large, but decided that it would be hard to improve upon the attached message, shared by Thomas A. Blackwell, M.D., F.A.C.P, Associate Dean for Graduate Medical Education.

I know you will join me in extending our deepest sympathy to Dr. LeBlanc’s family, colleagues and friends.

 

Sincerely yours,

DOJ_sig
Danny O. Jacobs, MD, MPH, FACS
Executive Vice President, Provost and
Dean of the School of Medicine
Thomas N. & Gleaves T. James Distinguished Chair

Separator bar for news items

July 23, 2014

Paul Bristol, MBAI am pleased to announce that Paul Bristol, MBA, will be joining us as Administrator for Primary Care Services in early August.

Mr. Bristol brings leadership experience and a wealth of expertise to his new role, with a background that encompasses finance, human resources, IT, facility management and faculty support.

He comes to UTMB from the University of Michigan in Ann Arbor, where he has worked for more than a decade in various departments, most recently as Administrator of the Vascular Surgery Section and Diagnostic Vascular Labs (DVUs) at multiple sites such as the University of Michigan Hospital, North Campus Research Complex (NCRC), Briarwood Health Associates (DVU), Cardiovascular Center (Clinical/Surgical/DVU), Dominos Farm (DVU) and remote Vein Clinics. In this role, he oversaw clinical, surgical and research operations; organized community outreach; managed space; increased revenue and market share while improving patient care; and supervised management staff.

As Administrator for the Cell and Developmental Biology Department, Mr. Bristol implemented both a new financial system to track project activity and a shared services model to support departmental accounting, and he helped develop the Basic Sciences Medical School incentive plan to reward faculty with greater than 50% salary coverage on sponsored funds. Other positions held by Mr. Bristol include Business and Human Resources Manager for the Chemistry Department and Senior Budget Analyst for the Dean’s Office, College of Literature, Science and Arts. While at the University of Michigan, he participated in such groups as the Wound Care Clinic Steering Committee, Medical School Post Award Modernization and the LSA Human Resource Classification Committee.

Mr. Bristol previously worked as a Manager, Financial Analyses and Recurring Revenue for Creative Solutions in Dexter, Michigan, and Project Controller for Deloitte & Touche in Dallas, Texas. He holds a certificate in Lean Healthcare Training, a BA in Communications from the University of Michigan and an MBA in Finance from Keller Graduate School in Atlanta, Georgia.

Please join me in welcoming Mr. Bristol!

DOJ_sig
Danny O. Jacobs, MD, MPH, FACS
Executive Vice President, Provost and
Dean of the School of Medicine
Thomas N. & Gleaves T. James Distinguished Chair

Separator bar for news items

July 23, 2014

Dr. Bukreyev I am pleased to announce that Alexander Bukreyev, PhD, Professor in the Departments of Pathology and Microbiology & Immunology, has been awarded roles on multiple five-year grants funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the Defense Treaty Reduction Agency (DTRA) and totaling more than $6.58 million. Through these projects, Dr. Bukreyev will work to develop antibodies and small molecules to treat Ebola and Marburg infections, investigate their pathogenetic mechanisms and study the innate immunity that allows bats to harbor these viruses.

The grants are administered through the Icahn School of Medicine at Mount Sinai (Dr. Chris Basler). In one grant, Dr. Bukreyev will work on testing and developing drugs to treat these viruses as principal investigator of Project 3, “Therapeutics Targeting Filoviral Interferon-antagonist and Replication Functions: Small Molecules Disabling Dephosphorylation of Ebola and Marburg" ($1,081,253) and principal investigator of Core B “Therapeutics Targeting Filoviral Interferon-antagonist and Replication Function” ($2,469,571). In another grant, Dr. Bukreyev will investigate immune responses caused by the Ebola and Marburg viruses as principal investigator of Project 2, "Mechanisms of ‘Immune Paralysis’ Caused by Filoviruses,” for $1,707,254.

Dr. Bukreyev also will receive $1,320,028 as co-investigator and principal investigator of the UTMB subcontract “Comparative Immunology of Rousettus Aegyptiacus Reservoir of Filovirus” funded by the DTRA.

Before joining UTMB in 2010, Dr. Bukreyev worked as a Research Fellow and Staff Scientist at the Laboratory of Infectious Diseases, NIAID, garnering honors including the Performance Award in Recognition of Special Achievement in Support of the Mission of the National Institute of Allergy and Infectious Diseases several years in a row. This year, he served on both the Organizing Committee of the 6th International Symposium on Filoviruses and on the NIH Vaccines Against Microbial Diseases (VMD) Study Section. He is a member of UTMB’s Galveston National Laboratory, the UTMB Center for Biodefense and Emerging Infectious Diseases and the UTMB Institute for Human Infections and Immunity, as well as a Senior Scientist for UTMB’s Sealy Center for Vaccine Development.

Please join me in congratulating Dr. Bukreyev on his grant awards.

DOJ_sig
Danny O. Jacobs, MD, MPH, FACS
Executive Vice President, Provost and
Dean of the School of Medicine
Thomas N. & Gleaves T. James Distinguished Chair

Separator bar for news items

 

Read more news ...

News from 2013